May 21, 2019
- Late-breaking data for Abbott's investigational clip-based tricuspid heart valve repair system presented at EuroPCR
- Data suggest the first-of-its-kind device reduces difficult-to-treat tricuspid regurgitation at 30 days
- Study builds upon Abbott's success with its proven MitraClip™ clip-based technology in treating a similar disease on the left side of the heart